Selecta Biosciences, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2008-01-01
- Employees
- 64
- Market Cap
- -
- Website
- http://www.selectabio.com
A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA
- First Posted Date
- 2023-03-21
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- Selecta Biosciences, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05778877
- Locations
- 🇺🇸
National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States
A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Selecta Biosciences, Inc.
- Target Recruit Count
- 170
- Registration Number
- NCT03905512
- Locations
- 🇺🇸
Panax Clinical Research, Miami Lakes, Florida, United States
🇺🇸Great Lakes Clinical Trials, Chicago, Illinois, United States
🇺🇸DJL Clinical Research, Charlotte, North Carolina, United States
Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers
- First Posted Date
- 2017-05-11
- Last Posted Date
- 2018-11-16
- Lead Sponsor
- Selecta Biosciences, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT03148925
- Locations
- 🇧🇪
SGS LSS Clinical Pharmacology Unit, Antwerpen, Belgium
Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid
- Conditions
- Interventions
- First Posted Date
- 2016-11-09
- Last Posted Date
- 2022-02-14
- Lead Sponsor
- Selecta Biosciences, Inc.
- Target Recruit Count
- 152
- Registration Number
- NCT02959918
- Locations
- 🇺🇸
Tri West Research Associates LLC, El Cajon, California, United States
🇺🇸Omega Research Consultants LLC, DeBary, Florida, United States
🇺🇸East-West Medical Research Institute, Honolulu, Hawaii, United States
Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels
- First Posted Date
- 2016-01-07
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- Selecta Biosciences, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT02648269
- Locations
- 🇺🇸
Orlando Clinical Research Center, Inc., Orlando, Florida, United States
🇺🇸Miami Research Associates, Miami, Florida, United States
🇺🇸SNBL Clinical Pharmacology Center Inc., Baltimore, Maryland, United States
Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
- First Posted Date
- 2015-06-08
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Selecta Biosciences, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT02464605
- Locations
- 🇺🇸
Altoona Center for Clincal Research, Duncansville, Pennsylvania, United States
🇺🇸Metroplex Clinical Research Center, Dallas, Texas, United States
Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers
- First Posted Date
- 2011-11-23
- Last Posted Date
- 2016-01-07
- Lead Sponsor
- Selecta Biosciences, Inc.
- Target Recruit Count
- 82
- Registration Number
- NCT01478893
- Locations
- 🇧🇪
SGS LSS Clinical Pharmacology Unit, Antwerpen, Belgium